Related Experiment Video
Updated: Jul 26, 2026
10:19
Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Published on: November 10, 2014
[Benign thyroid nodule: what is the treatment? Personal experience]
M Costanzo1, L A M Caruso, D C Messina
1Università degli Studi di Catania, P.O.U.S. Luigi e S. Currò - Catania, Cattedra e Servizio Clinicizzato di Endocrinochirurgia.
Annali Italiani Di Chirurgia
|July 23, 2005
Summary
Lobe-isthmusectomy is a safe and effective surgical option for benign solitary thyroid nodules, offering fewer complications and shorter hospital stays compared to total thyroidectomy.
Area of Science:
- Endocrinology
- Surgical Oncology
- Thyroid Pathology
Context:
- Solitary thyroid nodules affect 2-5% of the Italian population.
- Diagnosis relies on clinical examination, laboratory tests, and ultrasonography.
- Benign thyroid disease management requires careful consideration of surgical options.
Purpose:
- To compare the efficacy and safety of lobe-isthmusectomy versus total thyroidectomy for benign solitary thyroid nodules.
- To evaluate risks of relapse and complications associated with each surgical approach.
- To assess the overall usefulness of lobe-isthmusectomy in selected cases.
Summary:
- A retrospective study of 80 patients with benign solitary thyroid nodules treated with lobe-isthmusectomy between 1994 and 2000.
- Seven patients required conversion to total thyroidectomy during the procedure.
- Operative mortality was zero, with encouraging long-term results at a three-year follow-up.
Impact:
- Lobe-isthmusectomy demonstrates fewer postoperative complications and reduced hospital stays.
- This approach is considered a primary treatment choice for benign solitary thyroid nodules.
- The findings support lobe-isthmusectomy as a favorable surgical option, minimizing patient morbidity.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...